SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Mira Pharmaceuticals initiated with Buy rating and $3.50 target

Maxim Group initiated coverage on MIRA Pharmaceuticals with a Buy rating and a $3.50 per-share price target, as reported by Benzinga via TradingView News.

MIRA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories